医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
环戊基(氧代)乙酸乙酯 | ethyl 2-cyclopentyl-2-oxoacetate | 33537-18-7 | C9H14O3 |
|
环戊基(喹啉-2-基)甲胺 | Cyclopentyl(quinolin-2-YL)methanamine | 1159983-15-9 | C15H18N2 |
|
环戊丙酸宝丹酮 | Boldenone Cypionate | 106505-90-2 | C27H38O3 |
|
环庚烷磺酰氯 | cycloheptylsulfonyl chloride | 187143-10-8 | C7H13ClO2S |
|
环双(百草枯-1,4-亚苯基)四(六氟磷酸盐) | Cyclobis(paraquat-1,4-phenylene) Tetrakis(hexafluorophosphate) | 117271-77-9 | C36H32F24N4P4 |
|
环十一酮 | cycloundecanone | 878-13-7 | C11H20O |
|
环亮氨酸甲酯盐酸盐 | cycloleucine methyl ester hydrochloride | 60421-23-0 | C7H13NO2*ClH |
|
环亚丙基乙酸乙酯 | ethyl cyclopropenylideneacetate | 74592-36-2 | C7H10O2 |
|
环丙甲氧基胺 | O-cyclopropylmethyl-hydroxylamine | 75647-90-4 | C4H9NO |
|
环丙基异腈 | cyclopropyl isocyanide | 58644-53-4 | C4H5N |
|
环丙基亚磺酸酯 | 5,7-dioxa-6-thia-spiro[2.5]octane 6-oxide | 89729-09-9 | C5H8O3S |
|
环丙基-吡啶-3-甲胺 | N-(pyridin-3-ylmethyl)cyclopropylamine | 183609-18-9 | C9H12N2 |
|
环丙基-(2,4-二氯-嘧啶 -5-甲基)-胺 | N-((2,4-Dichloropyrimidin-5-yl)methyl)cyclopropanamine | 1289388-21-1 | C8H9Cl2N3 |
|
环丙基(3-嘧啶基)甲酮 | cyclopropylpyridin-3-yl methanone | 24966-13-0 | C9H9NO |
|
环丙嘧啶醇 | ancymidole | 12771-68-5 | C15H16N2O2 |
|
环丙嘧啶酸 | aminocyclopyrachlor | 858956-08-8 | C8H8ClN3O2 |
|
犬尿酸-d5 | Kynurenic Acid-d5 | 350820-13-2 | C10H7NO3 |
|
犬尿胺二氢溴酸盐 | Kynuramine dihydrobromide | 304-47-2 | 2BrH*C9H12N2O |
|
特拉匹韦中间体2 | (3S)-3-amino-N-cyclopropyl-2-hydroxyhexanamide hydrochloride | 850252-34-5 | C9H18N2O2*ClH |
|
特拉匹韦中间体 | tert-butyl (1S,3aR,6aS)-octahydrocyclopenta[c]pyrrole-1-carboxylate oxalate | 907606-68-2 | C2H2O4*C12H21NO2 |
|
特戊酸锌 | Trimethylacetatozinc | 15827-10-8 | C5H10O2Zn |
|
牡丹酚苷 | paeonoside | 20309-70-0 | C15H20O8 |
|
牛磺鹅去氧胆酸钠 | Taurine,7alpha-dihydroxy-5beta-cholan-24-oyl)-sodium salt | 6009-98-9 | C26H45NNaO6S+ |
|
牛磺胺 | Taurultam | 38668-01-8 | C3H8N2O2S |
|
爱沙替尼 | ensartinib | 1370651-20-9 | C26H27Cl2FN6O3 |
|
烯丙基苄基醚 | benzyl allyl ether | 14593-43-2 | C10H12O |
|
烯丙基三丁基鏻溴化物 | prop-2-enyl(tri-n-butyl)phosphonium bromide | 55894-18-3 | Br*C15H32P |
|
烟酸钠 | Nicotinic acid sodium | 54-86-4 | C6H5NNaO2 |
|
烟酸与3,7-二氢-1,3-二甲基-7-[2-[(3-吡啶甲基)氨基]乙基]-1H-嘌呤-2,6-二酮的化合物(1:1) | 7-(ss-3'-Picolylaminoaethyl)-theophyllin-nicotinat | 10058-07-8 | C6H5NO2*C15H18N6O2 |
|
烟酰苯胺 | N-phenylnicotinamide | 1752-96-1 | C12H10N2O |
|
烟酰胺氢碘 | nicotinic acid amide; hydriodide | 3726-23-6 | C6H7N2O*I |
|
炔丙基α-D-吡喃甘露糖苷 | propargyl α-D-mannopyranoside | 854262-01-4 | C9H14O6 |
|
炔丙基-PEG2-胺 | 2-(2-(prop-2-yn-1-yloxy)ethoxy)ethan-1-amine | 944561-44-8 | C7H13NO2 |
|
灌木远志酮 A | 6H,7H-chromeno[4,3-b]chromene-6,7-dione | 38210-27-4 | C16H8O4 |
|
溴芬酸钠 | bromfenac | 91714-94-2 | C15H12BrNO3 |
|
溴甲基喹啉酮 | 4-(bromomethyl)quinolin-2(1H)-one | 4876-10-2 | C10H8BrNO |
|
溴巴坦 | brobactam | 26631-90-3 | C8H10BrNO3S |
|
溴化十二烷基吡啶 | 1-dodecylpyridinium bromide | 104-73-4 | Br*C17H30N |
|
溴代肉豆蔻基吡啶 | N-tetradecylpyridinium bromide | 1155-74-4 | Br*C19H34N |
|
溴代四苄基-α-D-吡喃半乳糖 | tetra-O-benzyl-α-D-galactosyl bromide | 53081-30-4 | C34H35BrO5 |
|
溴代十六烷基吡啶 | cetylpyridinium bromide | 140-72-7 | Br*C21H38N |
|
溴代乙酸酐 | bromoacetic anhydride | 13094-51-4 | C4H4Br2O3 |
|
溴代-3,4-二甲氧基苯乙酮 | 2-Bromo-1-(3,4-dimethoxyphenyl)ethanone | 1835-02-5 | C10H11BrO3 |
|
溴[3-(四氢-2H-吡喃-2-基氧基)苯基]镁 | Magnesium bromide 3-[(oxan-2-yl)oxy]benzen-1-ide (1/1/1) | 142402-62-8 | C11H13BrMgO2 |
|
溴(二氟)乙酰氯 | bromodifluoroacetyl chloride | 3832-48-2 | C2BrClF2O |
|
海藻酸铵 | 6-(2-Carboxy-4,5-dihydroxy-6-methoxyoxan-3-yl)oxy-4,5-dihydroxy-3-methoxyoxane-2-carboxylic acid | 9005-34-9 | C14H22O13 |
|
海绵核苷 | 2-Methoxyadenosine | 24723-77-1 | C11H15N5O5 |
|
海因 | 2,4-imidazolidinedione | 461-72-3 | C3H4N2O2 |
|
派瑞林D | Parylene D | 30501-29-2 | C16H12Cl4 |
|
洋地黄毒苷NHS酯 | (2,5-dioxopyrrolidin-1-yl) 6-[[2-[[(3S,5R,8R,9S,10S,12R,13S,17R)-12,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]acetyl]amino]hexanoate | 129273-26-3 | C35H50N2O10 |
|